PAQRs: A counteracting force to ceramides?

Molecular Pharmacology

Volumn 75, Issue 4, 2009, Pages 740-743

  Holland, William L ^a   Scherer, Philipp E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; ADENYLATE KINASE; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CERAMIDE DERIVATIVE; GLUCOSYLCERAMIDE; INSULIN; INTERLEUKIN 1; PROGESTERONE RECEPTOR; PROTEIN KINASE B; SPHINGOLIPID; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE RELEASE; ENZYME ACTIVITY; GENE OVEREXPRESSION; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; YEAST;

ANIMALS; CERAMIDES; HUMANS; INSULIN RESISTANCE; OBESITY; RECEPTORS, ADIPONECTIN; SECOND MESSENGER SYSTEMS;

EID: 63849250388     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.054817     Document Type: Review

References (27)

1. Chavez JA, Holland WL, Bär J, Sandhoff K, and Summers SA (2005) Acid cerami- dase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J Biol Chem 280:20148-20153.
2. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, Nawrocki AR, Rajala MW, Parlow AF, Cheeseboro L, et al. (2004) A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145:367-383.
3. Grigsby RJ and Dobrowsky RT (2001) Inhibition of ceramide production reverses TNF-induced insulin resistance. Biochem Biophys Res Commun 287:1121-1124.
4. Hojjati MR, Li Z, Zhou H, Tang S, Huan C, Ooi E, Lu S, and Jiang XC (2005) Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE- deficient mice. J Biol Chem 280:10284-10289.
5. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, et al. (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167-179.
6. Holland WL and Summers SA (2008) Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 29:381-402.
7. Kadowaki T and Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439-451.
8. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117:26212637.
9. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, et al. (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25866.
10. Liu Y, Michael MD, Kash S, Bensch WR, Monia BP, Murray SF, Otto KA, Syed SK, Bhanot S, Sloop KW, et al. (2007) Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 148:683-692.
11. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731-737.
12. Mao C and Obeid LM (2008) Ceramidases: regulators ofcellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim Biophys Acta1781:424-434.
13. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, and Ludwig DS (2005) A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352:1138-1145.
14. Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J, Tuinei J, Homma S, Jiang XC, Abel ED, et al. (2008) Ceramide is a cardiotoxin in lipotoxic cardiomy- opathy. J Lipid Res 49:2101-2112.
15. Park TS, Panek RL, Mueller SB, Hanselman JC, Rosebury WS, Robertson AW, Kindt EK, Homan R, Karathanasis SK, and Rekhter MD (2004) Inhibition of sphingo- myelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 110:3465-3471.
16. p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13018 -13022.
17. Santana P, Llanes L, Hernandez I, Gonzalez-Robayna I, Tabraue C, Gonzalez-Reyes J, Quintana J, Estevez F, Ruiz de Galarreta CM, and Fanjul LF (1996) Interleu- kin-1 beta stimulates sphingomyelin hydrolysis in cultured granulosa cells: evidence for a regulatory role ofceramide on progesterone and prostaglandin biosynthesis. Endocrinology 137:2480-2489.
18. q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749.
19. Stratford S, Hoehn KL, Liu F, and Summers SA (2004) Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem 279:36608-36615.
20. Tagami S, Inokuchi Ji J, Kabayama K, Yoshimura H, Kitamura F, Uemura S, Ogawa C, Ishii A, Saito M, Ohtsuka Y, et al. (2002) Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem 277:3085-3092.
21. Trujillo ME and Scherer PE (2006) Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27:762-778.
22. Villa NY, Kupchak BR, Garitaonandia I, Smith JL, Alonso E, Alford C, Cowart LA, Hannun YA, and Lyons TJ (2009) Sphingolipids function as downstream effectors of a fungal PAQR. Mol Pharmacol 75:866-875.
23. Wang ZV and Scherer PE (2008) Adiponectin, cardiovascular function, and hypertension. Hypertension 51:8-14.
24. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769.
25. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295.
26. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T, et al. (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13:332-339.
27. Zhu Q, Jin JF, Shan XH, Liu CP, Mao XD, Xu KF, and Liu C (2008) Chronic activation of neutral ceramidase protects beta-cells against cytokine-induced apoptosis. Acta Pharmacol Sin 29:593-599.